eGenesis
MA - CambridgeBiotechnology
Focus: eGenesis is a CRISPR-focused biotechnology company developing xenotransplantation solutions to address organ transplant shortages. The company is headquartered in Cambridge, MA and operates as a pre-revenue biotech with early-stage clinical assets.
Profile data last refreshed 3h ago · AI intelligence enriched 2mo ago
Open Jobs
7-3 this month
Stable — net -3 jobs in 30d
1 added, 4 removed. Backfill posture.
Should You Work at eGenesis?
AI assessmenteGenesis offers high scientific impact and frontier technology exposure for early-career gene therapy specialists, but carries meaningful execution and financial runway risk typical of pre-revenue xenotransplant biotech.
Why Work Here
- Pioneering CRISPR gene therapy applications in a large, unmet clinical need (organ transplantation) with significant commercial upside
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
metra® Extracorporeal Liver Cross-Circulation
Acute on Chronic Liver Failure (ACLF)Recent News · eGenesis(1)
Help build intelligence for eGenesis
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.